Disease | multiple myeloma |
Comorbidity | C0029456|osteoporosis |
Sentences | 3 |
PubMedID- 22082730 | Introduction: osteonecrosis of the jaw (onj) is an emerging condition in patients undergoing long-term administration of bisphosphonates (bp) for the treatment of osteoporosis and hypercalcaemia associated with malignancy, multiple myeloma, and metastatic breast and prostate cancers. |
PubMedID- 22952578 | The molecular mechanism responsible for the development of osteoporosis in myeloma is unknown. |
PubMedID- 23079689 | Osteomalacia, myelomatosis)to elucidate causes of osteoporosis and contributory factorsto assess the severity of osteoporosis to determine the prognosis of the disease, i.e. |
Page: 1